Indivior (INDV) Projected to Post Earnings on Thursday

Indivior (NASDAQ:INDVGet Free Report) will likely be issuing its quarterly earnings data before the market opens on Thursday, February 27th. Analysts expect the company to announce earnings of $0.32 per share and revenue of $259.30 million for the quarter.

Indivior Trading Up 0.7 %

Shares of NASDAQ INDV opened at $10.91 on Thursday. The stock has a market capitalization of $1.50 billion, a PE ratio of -272.63 and a beta of 0.73. The stock’s fifty day simple moving average is $11.56 and its two-hundred day simple moving average is $10.89. Indivior has a 12-month low of $7.33 and a 12-month high of $23.22.

Wall Street Analyst Weigh In

INDV has been the topic of several recent research reports. Piper Sandler reaffirmed an “overweight” rating and set a $16.00 target price (up previously from $15.00) on shares of Indivior in a research report on Friday, October 25th. RODMAN&RENSHAW raised Indivior to a “strong-buy” rating in a research report on Tuesday, January 28th. Finally, Rodman & Renshaw initiated coverage on Indivior in a research report on Tuesday, January 28th. They set a “buy” rating and a $16.00 target price on the stock.

Read Our Latest Research Report on INDV

About Indivior

(Get Free Report)

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.

Featured Stories

Earnings History for Indivior (NASDAQ:INDV)

Receive News & Ratings for Indivior Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Indivior and related companies with MarketBeat.com's FREE daily email newsletter.